Related Experiment Video
Updated: Aug 9, 2026

Lighting Up the Pathways to Caspase Activation Using Bimolecular Fluorescence Complementation
Published on: March 5, 2018
Structure of the TRAIL-DR5 complex reveals mechanisms conferring specificity in apoptotic initiation
J Mongkolsapaya1, J M Grimes, N Chen
1MRC Human Immunology Unit, Institute of Molecular Medicine, John Radcliffe Hospital, Oxford OX3 9DS, UK.
Abstract:
TRAIL, an apoptosis inducing ligand, has at least four cell surface receptors including the death receptor DR5. Here we report the crystal structure at 2.2 A resolution of a complex between TRAIL and the extracellular region of DR5. TRAIL forms a central homotrimer around which three DR5 molecules bind. Radical differences in the surface charge of the ligand, together with variation in the alignment of the two receptor domains confer specificity between members of these ligand and receptor families. The existence of a switch mechanism allowing variation in receptor domain alignment may mean that it is possible to engineer receptors with multiple specificities by exploiting contact positions unique to individual receptor-ligand pairs.
Insights
The crystal structure reveals how Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) binds to its receptor DR5, detailing the molecular interactions that control cell death signaling pathways.
Area of Science:
- Structural Biology
- Molecular Biology
- Immunology
Background:
- Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) is a key mediator of apoptosis.
- TRAIL interacts with multiple cell surface receptors, including Death Receptor 5 (DR5), to initiate programmed cell death.
Purpose of the Study:
- To elucidate the structural basis of the interaction between TRAIL and the extracellular domain of DR5.
- To understand the molecular mechanisms conferring specificity in TRAIL-receptor interactions.
Main Methods:
- X-ray crystallography was employed to determine the structure of the TRAIL-DR5 complex at 2.2 Å resolution.
Main Results:
- The crystal structure reveals that TRAIL forms a homotrimer, with three DR5 molecules binding around it.
- Significant differences in surface charge between TRAIL and DR5, along with variable receptor domain alignment, dictate binding specificity.
- A potential switch mechanism in receptor domain alignment was identified.
Conclusions:
- The determined structure provides critical insights into the molecular recognition events governing TRAIL-mediated apoptosis.
- Understanding these interactions may enable the engineering of novel receptors with altered or multiple specificities for therapeutic applications.
Related Concept Videos
Restarting Stalled Replication Forks
Apoptosis
Caspases
The Extrinsic Apoptotic Pathway
The Intrinsic Apoptotic Pathway
Cellular Injury V: Apoptosis and Autophagy

